| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.048 | 0.2 |